✦ LIBER ✦

Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination

✍ Scribed by U.A. Sanli; G. Gorumlu; C. Erten; M.K. Gul; E. Cengiz; Y. Kucukzeybek; B. Karaca; H. Atmaca; S. Uzunoglu; B. Karabulut; R. Uslu

Book ID: 108084716
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 402 KB
Volume: 33
Category: Article
ISSN: 1065-6995
DOI: 10.1016/j.cellbi.2009.08.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overcoming drug resistance in hormone- a

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

✍ Ercument Cengiz; Burcak Karaca; Yuksel Kucukzeybek; Gurbuz Gorumlu; Mustafa K. G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

Regulation of apoptosis-related molecule

Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

✍ Bulent Karabulut; Burcak Karaca; Harika Atmaca; Asli Kisim; Selim Uzunoglu; Canf 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 398 KB

Cell-cycle arrest and p53-independent in

Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells

✍ Rosanna M. C. Cattaneo-Pangrazzi; Herbert Schott; Heidi Wunderli-Allenspach; Bar 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 334 KB

The novel heterodinucleoside dimer 5-FdU

The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145

✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell